As a university student, Dalton Signor was troubled by how many people around him smoked or vaped, including his grandmother ...

"Patients diagnosed with headache may benefit from concurrent behavioral health evaluation and treatment," researchers said.

The ACP issued new clinical guidance on preventing episodic migraines, classified as one to 14 headache days per month, in ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

After adjusting for potential confounders (age, sex, race, use of birth control, pregnancy), findings showed propranolol use was associated with a significant reduction in the risk of stroke among ...

The Clinical Guidelines Committee of the American College of Physicians (ACP) has released a new clinical guideline on the ...

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant adults in outpatient settings.

With historical data showing migraine to be underdiagnosed and undertreated, new guidance from the American College of ...

In this systematic review, patients with episodic migraine preferred oral pharmacologic treatments that reduced the severity, ...

Migraines affect millions worldwide, yet remain widely misunderstood. This neurological condition extends far beyond typical headache symptoms, often ...

A common drug used to prevent migraines might have an additional benefit -- protecting women against stroke.Women takin ...